Chardan: After Dicerna Pharma's 370% Run, Wait For Better Entry Point
March 09, 2018 at 09:50 AM EST
Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) could become a player in the emerging field of small RNA interference, or RNAi, according to ...